首页> 美国卫生研究院文献>Cancer Medicine >An antitumor peptide RS17‐targeted CD47 design synthesis and antitumor activity
【2h】

An antitumor peptide RS17‐targeted CD47 design synthesis and antitumor activity

机译:抗肿瘤肽RS17靶向CD47设计合成和抗肿瘤活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CD47 is a widely expressed transmembrane protein located on the surface of somatic cells. It mediates a variety of cellular processes including apoptosis, proliferation, adhesion, and migration. An important role for CD47 is the transmission of a “Don't eat me” signal by interacting with SIRPα on the macrophage surface membrane, thereby preventing the phagocytosis of normal cells. However, cancer cells can take advantage of this autogenous signal to protect themselves from phagocytosis, thus enabling immune escape. Blocking the interaction between CD47 and SIRPα has proven to be effective in removing cancer cells. The treatment of various cancers with CD47 monoclonal antibodies has also been validated.
机译:CD47是位于体细胞表面上的广泛表达的跨膜蛋白。它介导各种细胞过程,包括细胞凋亡,增殖,粘附和迁移。 CD47的重要作用是通过在巨噬细胞表面膜上与SiRPα相互作用来传播“不吃我”信号,从而防止正常细胞的吞噬作用。然而,癌细胞可以利用这种自生物信号来保护自己免受吞噬作用,从而使免疫逸出。阻断CD47和SiRPα之间的相互作用已被证明在去除癌细胞方面是有效的。还验证了用CD47单克隆抗体治疗各种癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号